AKR1B10 accelerates glycolysis through binding HK2 to promote the malignant progression of oral squamous cell carcinoma
Abstract Background Oral squamous cell carcinoma (OSCC) remains a rampant oral cavity neoplasm with high degree of aggressiveness. Aldo–keto reductase 1B10 (AKR1B10) that is an oxidoreductase dependent on nicotinamide adenine dinucleotide phosphate (NADPH) has been introduced to possess prognostic p...
Збережено в:
| Автори: | , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Springer
2024-04-01
|
| Серія: | Discover Oncology |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1007/s12672-024-00996-0 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|